(Q34155769)

31 July 2017

1 reference

title

Recommendations and rationale for the treatment of pelvic inflammatory disease (English)

1 reference

pelvic inflammatory diseases

31 July 2017

main subject

0 references

author name string

Oluwatosin Jaiyeoba

series ordinal

1

1 reference

31 July 2017

Gweneth Lazenby

series ordinal

2

1 reference

31 July 2017

David E Soper

series ordinal

3

1 reference

31 July 2017

publication date

1 January 2011

1 reference

Expert Review of Anti-infective Therapy

31 July 2017

published in

1 reference

31 July 2017

volume

9

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

61-70

1 reference

Polymicrobial etiology of acute pelvic inflammatory disease

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Chilamydia trachomatis infection in patients with acute salpingitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

The antimicrobial treatment of subacute endometritis: a proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Current trends in the diagnosis and treatment of tuboovarian abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Penetration and accumulation of moxifloxacin in uterine tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Persistence of Mycoplasma genitalium following azithromycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Azithromycin failure in Mycoplasma genitalium urethritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Epidemiology, pathogenesis and treatment of pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Mycoplasma genitalium -- an up-date

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Antimicrobial resistance associated with the treatment of bacterial vaginosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

Comparison of acute and subclinical pelvic inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.156

21 January 2018

Identifiers

DOI

10.1586/ERI.10.156

1 reference

31 July 2017

1 reference